← Back
Data updated: Mar 10, 2026
KINDEVA
Respiratory
KINDEVA is a specialty pharmaceutical company focused on Respiratory.
1996
Since
6
Drugs
-
Trials
10
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FENTANYL-75 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-100 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-100 2025-12-22
Labeling
FENTANYL-75 2024-10-31
REMS
FENTANYL-100 2024-10-31
REMS
FENTANYL-75 2024-10-31
REMS
FENTANYL-100 2024-10-31
REMS
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 1996-08-15
- Latest
- 2025-12-22
- Applications
- 2